Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
CNSP
#4006
CNS Pharmaceuticals, Inc. Common Stock
3.1
6
+4.29%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+4.29%
Monatliche Änderung
-48.11%
6 month change
-49.76%
Jahresänderung
+35.62%
Vorheriger Schlusskurs
3.0
3
Open
3.1
7
Bid
Ask
Low
3.0
9
High
3.1
7
Volumen
4
Märkte
Aktien
Gesundheitswesen
CNSP
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
28.11
44.48
74.21
354.5
245.37 K
—
Valuation ratios
Enterprise value
—
—
—
—
—
—
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.6
-1.6
-1.17
-11.08
-1.71
-1.11
Return on equity %
0.68
-2.12
-1.88
4.25
-2.41
-1.41
Return on invested capital %
6 290.05
-4 005
-4 206.49
-11.53 K
-15.3 K
—
Gross margin %
100
—
100
100
100
—
Operating margin %
597.26 K
—
490.75 K
-69.39 K
-7.84 M
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
597.47 K
—
490.97 K
-69.33 K
-7.82 M
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
8.13
3.5
2.55
0.26
3.43
24.41
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
-0
0
0
0
Solvency ratios
Debt to assets ratio
0.06
0.09
0.07
—
—
—
Debt to equity ratio
0.07
0.12
0.11
—
—
—
Long term debt to total assets ratio
0.03
0.04
0.03
0.18
0.04
0.06
Long term debt to total equity ratio
0.03
0.06
0.05
-0.07
0.05
0.08
Per share metrics
Operating cash flow per share
—
—
-232.6 K
-112.6 K
-537.25
-204.35
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
18.94 K
—
—
—
Cash per share
—
—
221.53 K
4 369.53
202.85
310.69
Net current asset value per share
—
—
276.81 K
12.67 K
271.82
390.8
Tangible book value per share
—
—
179.17 K
-35.29 K
193.91
295.38
Working capital per share
—
—
168.41 K
-36.17 K
192.58
292.07
Book value per share
—
—
179.17 K
-35.29 K
193.91
295.38
Nachrichten
CNS Pharmaceuticals ernennt drei neue Führungskräfte im Zuge strategischer Neuausrichtung
CNS Pharmaceuticals appoints three new executives to leadership team
CNS Pharmaceuticals’ new CEO outlines strategic overhaul
Corero Network Security erweitert DDoS-Schutzplattform als Reaktion auf neue Angriffsmuster
Corero Network Security reports DDoS protection platform enhancements
CNS Pharmaceuticals: Aktie gibt nach CEO-Wechsel nach
CNS Pharmaceuticals stock falls after CEO steps down
CNS Pharmaceuticals appoints Rami Levin as new CEO, replacing Climaco
CNS Pharmaceuticals: Aktionäre stimmen Kapitalerhöhung und Wahl des Verwaltungsrats zu
CNS Pharmaceuticals shareholders approve share increases and board elections at annual meeting
CNS Pharmaceuticals, Inc. (CNSP) Shareholder/Analyst Call Prepared Remarks Transcript
Corero Network Security meldet deutliches Wachstum beim Auftragseingang im 3. Quartal